Ackermann Michael (CIK 0001791249)

Latest company ownership

Shares held
1,204,016
Last filed at
Dec 3, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 5, 2022 May 9, 2022 Tarsus Pharmaceuticals, Inc. Director Buy 95.0 +100,000 8.31% ✗ $1.4M
Dec 1, 2021 Dec 3, 2021 Tarsus Pharmaceuticals, Inc. Director Sell 48.8 -5,833 -0.48% ✓ $143.9K
Nov 1, 2021 Nov 3, 2021 Tarsus Pharmaceuticals, Inc. Director Sell 48.8 -5,833 -0.48% ✓ $162.3K
Oct 12, 2021 Oct 14, 2021 Tarsus Pharmaceuticals, Inc. Director Sell 48.8 -5,633 -0.46% ✓ $148K
Oct 8, 2021 Oct 12, 2021 Tarsus Pharmaceuticals, Inc. Director Sell 58.8 -200 -0.02% ✓ $5K
Sep 1, 2021 Sep 3, 2021 Tarsus Pharmaceuticals, Inc. Director Sell 48.8 -5,833 -0.48% ✓ $147.2K
Aug 11, 2021 Aug 12, 2021 Tarsus Pharmaceuticals, Inc. Director Sell 55.0 -621 -0.05% ✓ $15.6K
Aug 6, 2021 Aug 10, 2021 Tarsus Pharmaceuticals, Inc. Director Sell 48.8 -3,829 -0.31% ✓ $95.7K
Aug 5, 2021 Aug 6, 2021 Tarsus Pharmaceuticals, Inc. Director Sell 53.8 -1,383 -0.11% ✓ $34.6K